Recurring losses resulting from front-loaded R&D
First written in FY2024. 1 of 6 entries say "Achieved", first in 2026-03-06. Latest entry: FY2027-H1.
The whole theme swung hardest in 2017: 3 of 6 companies on the "Worse" side.
6 other companies' latest entry also says "Other".
- FY2027-H1Loss recorded for the interim periodAnnual report
「Under these circumstances, the Company's results for the interim accounting period were revenue of ¥467,370 thousand, an operating loss of ¥621,567 thousand, an ordinary loss of ¥551,683 thousand and an interim net loss of ¥554,307 thousand.」
Although the previous fiscal year was profitable on a full-year basis, the interim accounting period recorded an operating loss of ¥621,567 thousand, an ordinary loss of ¥551,683 thousand and an interim net loss of ¥554,307 thousand, changing to a loss on an interim basis. - 2026-05-15Cited as achievedRevision to earnings forecast
「Against this backdrop, for the cumulative first-quarter period, net sales were ¥465.870 million, operating loss was ¥75.164 million, ordinary loss was ¥56.487 million and quarterly net loss was ¥58.160 million.」
Following the recognition of full-year profit in the previous fiscal year, the Company recorded an operating loss and quarterly net loss in the first quarter. - FY2025Profit recorded for the full fiscal yearAnnual report
「As a result, the Company's results for the fiscal year were revenue of ¥3,026,500 thousand, operating income of ¥272,156 thousand, ordinary income of ¥288,985 thousand and net income of ¥190,608 thousand.」
For the fiscal year, revenue was ¥3,026,500 thousand, operating income was ¥272,156 thousand and net income was ¥190,608 thousand, changing from a loss in the previous fiscal year to full-year profit. - 2026-03-06AchievedGeneral Meetings of Shareholders
「For the fiscal year, net sales were ¥3,026.500 million, operating income was ¥272.156 million, ordinary income was ¥288.985 million and net income was ¥190.608 million.」
In contrast with the previous structure of continued losses driven by upfront research and development spending, the Company recorded operating income, ordinary income and net income in the 10th fiscal year. - FY2026-H1Profit recorded for the interim periodAnnual report
「Under these circumstances, the Company's results for the interim accounting period were revenue of ¥1,919,350 thousand, operating income of ¥896,031 thousand, ordinary income of ¥845,313 thousand and interim net income of ¥707,044 thousand.」
Despite recording R&D expenses of ¥722,233 thousand, recognition of development milestone income resulted in operating income of ¥896,031 thousand and interim net income of ¥707,044 thousand, changing from the previous recurring-loss position to profit for the period. - FY2024First statedAnnual report
「From the fifth through the ninth fiscal years, the Company recorded ordinary losses and net losses due to front-loaded investment in R&D expenses within selling, general and administrative expenses.」
Front-loaded R&D spending resulted in operating losses and net losses even after revenue began to increase.